Skip to main content

Research Repository

Advanced Search

NIHR Advanced Fellowship Programme - Stigma related to prostate cancer in black men

People Involved

Project Description

The DESTIGMATISE study aims to understand and address stigma related to prostate cancer in Black men. Evidence shows that prostate cancer disproportionately affects 1 in 4 Black men compared with 1 in 8 White and 1 in 13 Asian men. While early diagnosis improves outcomes from prostate cancer, there are indications that self, public and structural stigma impedes social interactions, decision-making and early help-seeking by men of Black African and Caribbean descent, leading to delays in diagnosis and increased mortality. However, it is unclear how best to tackle this stigma within the Black cultural context due to a lack of research. We will work together with members of Black communities, NHS providers and wider stakeholders across the UK, to address this gap in the evidence base. Beyond seeking to understand an important problem, the research will co-develop with Black communities, culturally intelligent solutions to address stigma and hopefully address ethnic inequalities and improve the experiences and outcomes from prostate cancer among men of Black African and Caribbean descent - who are disproportionately affected by the illness but underrepresented in research.

Type of Project Fellowship
Status Project Live
Funder(s) National Institute for Health Research
Value £999,620.00
Project Dates Mar 1, 2025 - Feb 28, 2030
This project contributes to the following UN Sustainable Development Goals
SDG 3 - Good Health and Well-Being

You might also like

TRANSFORM: YCR Cancercare: Experiences of diagnostic pathways and cancer care during the COVID-19 pandemic Apr 1, 2021 - Oct 31, 2024
The global coronavirus (COVID-19) outbreak has led to the disruption of cancer care services, as healthcare resources (personnel, facilities) were reprioritised to respond to the pandemic. The implications of this for cancer outcomes and patients’ ps... Read More about TRANSFORM: YCR Cancercare: Experiences of diagnostic pathways and cancer care during the COVID-19 pandemic.

Evaluating the effectiveness and acceptability of free door to door transport to increase the uptake of breast screening appointments in Yorkshire: A cluster randomised GP pilot trial Jun 1, 2023 - Jan 31, 2026
Breast screening is one of the key tools in identifying breast cancer at an early stage. It is currently offered to women between the ages of 50 and 70 on a three yearly cycle. Whilst nationally breast screening uptake is 70% this leaves 30% of wom... Read More about Evaluating the effectiveness and acceptability of free door to door transport to increase the uptake of breast screening appointments in Yorkshire: A cluster randomised GP pilot trial.